Wong Keit Men, Babetto Elisabetta, Beirowski Bogdan
Hunter James Kelly Research Institute, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.
Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.
Neural Regen Res. 2017 Apr;12(4):518-524. doi: 10.4103/1673-5374.205000.
Axonal degeneration is a pivotal feature of many neurodegenerative conditions and substantially accounts for neurological morbidity. A widely used experimental model to study the mechanisms of axonal degeneration is Wallerian degeneration (WD), which occurs after acute axonal injury. In the peripheral nervous system (PNS), WD is characterized by swift dismantling and clearance of injured axons with their myelin sheaths. This is a prerequisite for successful axonal regeneration. In the central nervous system (CNS), WD is much slower, which significantly contributes to failed axonal regeneration. Although it is well-documented that Schwann cells (SCs) have a critical role in the regenerative potential of the PNS, to date we have only scarce knowledge as to how SCs 'sense' axonal injury and immediately respond to it. In this regard, it remains unknown as to whether SCs play the role of a passive bystander or an active director during the execution of the highly orchestrated disintegration program of axons. Older reports, together with more recent studies, suggest that SCs mount dynamic injury responses minutes after axonal injury, long before axonal breakdown occurs. The swift SC response to axonal injury could play either a pro-degenerative role, or alternatively a supportive role, to the integrity of distressed axons that have not yet committed to degenerate. Indeed, supporting the latter concept, recent findings in a chronic PNS neurodegeneration model indicate that deactivation of a key molecule promoting SC injury responses exacerbates axonal loss. If this holds true in a broader spectrum of conditions, it may provide the grounds for the development of new glia-centric therapeutic approaches to counteract axonal loss.
轴突退变是许多神经退行性疾病的关键特征,在很大程度上导致了神经功能障碍。一种广泛用于研究轴突退变机制的实验模型是华勒氏变性(WD),它发生在急性轴突损伤后。在周围神经系统(PNS)中,WD的特征是受损轴突及其髓鞘迅速分解和清除。这是轴突成功再生的先决条件。在中枢神经系统(CNS)中,WD的速度要慢得多,这显著导致了轴突再生失败。尽管有充分的文献记载施万细胞(SCs)在PNS的再生潜能中起关键作用,但迄今为止,我们对SCs如何“感知”轴突损伤并立即做出反应知之甚少。在这方面,SCs在轴突高度协调的解体程序执行过程中是扮演被动旁观者还是主动引导者的角色仍不清楚。早期报告以及最近的研究表明,SCs在轴突损伤数分钟后就会产生动态损伤反应,远在轴突崩解之前。SCs对轴突损伤的迅速反应可能对尚未注定退变的受损轴突的完整性起到促退变作用或支持作用。事实上,支持后一种观点的是,慢性PNS神经退行性疾病模型中的最新发现表明,促进SCs损伤反应的关键分子失活会加剧轴突损失。如果在更广泛的情况下都是如此,那么这可能为开发以神经胶质细胞为中心的新治疗方法来对抗轴突损失提供依据。